Vote NO Pfizer offer, page-531

simple VOTE NO, alone for the fact that entire RAP should be sold, with IP they've been developing for 10 years. Clearly Pfizer is mainly intersted in the Covid Algo, for valid reasons, A: if you're that big simply buy the competition, B: use it as additional revenue stream. So I could understand and consider in selling maybe only the Covid Algo, but why entire firm and IP. This offer is simply a validation of our product and management should beef up their game and take this as confirmation we're heading in the right direction.